Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2006-05-09 Interim / Quarterly Rep…
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
QUARTERLY FILING FORM 10QSB
Interim / Quarterly Report Classification · 100% confidence The document is titled as a Form 10-QSB, which is a quarterly report filed under the Securities Exchange Act of 1934. It covers the quarterly period ended March 31, 2006. The text includes unaudited financial statements, management's discussion and analysis of financial condition and results of operations, and notes to the financial statements. The content is consistent with a comprehensive interim financial report for a period shorter than a full fiscal year, containing actual financial data and analysis. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2006-05-09 English
YEAR ENDED DECEMBER 31, 2005
Annual Report Classification · 100% confidence The document is a Form 10-KSB filed with the U.S. Securities and Exchange Commission for the fiscal year ended December 31, 2005. It is titled as an Annual Report pursuant to the Securities Exchange Act of 1934. The text includes detailed business description, management discussion and analysis, market information, and financial data typical of an annual report. The document length is 15,000 characters, indicating it is a full report rather than a brief announcement. There is no indication that this is a proxy statement, earnings release, or other filing type. Therefore, the document fits the definition of an Annual Report (10-K).
2006-03-30 English
AMENDED 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K/A filed with the SEC, specifically reporting a change in the company's certifying accountant. It details the dismissal of the previous auditor and engagement of a new auditor, including statements about audit opinions and disagreements. The content focuses on changes related to accountants and financial statements but does not contain actual financial statements or detailed financial data. It is a regulatory filing informing about a change in auditors rather than a full audit report or annual report. Therefore, it fits best under Regulatory Filings (RNS).
2006-01-06 English
Regulatory Filings 2006
Regulatory Filings
2006-01-06 English
ACCOUNTANT CHANGE
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details a change in the company's certifying accountant, including the termination of the previous accountant and engagement of a new one. It includes information about the audit reports, disagreements, and consultations related to accounting principles. This type of filing is related to changes in accountants and financial statement matters but is not a full audit report or annual report. It is a regulatory announcement about accounting changes, fitting the category of Regulatory Filings (RNS) as it does not contain full financial statements or detailed audit results but rather a disclosure of a significant event.
2006-01-06 English
OCIS FORM 10QSB-SEPTEMBER 30, 2005
Interim / Quarterly Report Classification · 100% confidence The document is a Form 10-QSB filed with the U.S. Securities and Exchange Commission for the quarterly period ended September 30, 2005. It contains unaudited financial statements, including balance sheets, statements of operations, cash flows, and notes to the financial statements. It also includes management's discussion and analysis of financial condition and results of operations. The presence of detailed financial data and analysis for a period shorter than a full fiscal year confirms this is a quarterly report. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2005-11-14 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.